The 2023 ART guideline introduces simplified ART provision and harmonised methods of management of children, adolescents and adults, as well as pregnant women living with HIV/AIDS, TB and other common opportunistic infections. 

The guidelines also provide guidance on the use of Dolutegravir (DTG) dispersible tablets for children from 3kg and 4 weeks old. 

The guidelines have been revised with the Differentiated Models of Care SOPs to ensure simultaneous consideration and alignment of clinical, adherence and service delivery updates.

The National Patient Safety Incidents (PSI) reporting and learning guideline was published in 2017 and came into effect on 1 April 2018 and was revised in 2021 with implementation on 1 April 2022. The training module covers the content of the National PSI reporting and learning guideline and outlines the procedure to follow to manage PSIs and learn from errors to prevent reoccurrence.

The ACC Programme for healthcare professionals was designed to strengthen the South African Government’s ability in addressing challenges of sustainable clinical capacity within the National Department of Health in the context of a rapidly maturing HIV and TB epidemic. The curriculum will focus on providing healthcare professionals with the core knowledge and skills required to diagnose and manage unstable HIV patients with commonly observed opportunistic infections and other co-morbidities, in addition to those failing antiretroviral treatment (ART).